Skip to main content
PMC home page
Epidemiology and Infection logoLink to Epidemiology and Infection
. 1996 Oct;117(2):313–325. doi: 10.1017/s0950268800001497

Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areas.

W J Edmunds 1, G F Medley 1, D J Nokes 1, C J O'Callaghan 1, H C Whittle 1, A J Hall 1
PMCID: PMC2271713  PMID: 8870629

Abstract

This paper uses meta-analysis of published data and a deterministic mathematical model of hepatitis B virus (HBV) transmission to describe the patterns of HBV infection in high endemicity areas. We describe the association between the prevalence of carriers and a simple measure of the rate of infection, the age at which half the population have been infected (A50), and assess the contribution of horizontal and perinatal transmission to this association. We found that the two main hyper-endemic areas of sub-Saharan Africa and east Asia have similar prevalences of carriers and values of A50, and that there is a negative nonlinear relationship between A50 and the prevalence of carriers in high endemicity areas (Spearman's Rank, P = 0.0086). We quantified the risk of perinatal transmission and the age-dependent of infection to allow a comparison between the main hyper-endemic areas. East Asia was found to have higher prevalences of HBeAg positive mothers and a greater risk of perinatal transmission from HBeAg positive mothers than sub-Saharan Africa, though the differences were not statistically significant. However, the two areas have similar magnitudes and age-dependent rates of horizontal transmission. Results of a simple compartmental model suggest that similar rates of horizontal transmission are sufficient to generate the similar patterns between A50 and the prevalences of carriers. Interrupting horizontal transmission by mass immunization is expected to have a significant, nonlinear impact on the rate of acquisition of new carriers.

Full text

PDF
321

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Al-Nakib B., el-Mekki A., Al-Kandari S., Nordenfelt E., Al-Nakib W. Hepatitis B virus perinatal transmission among Arab women. Ann Trop Paediatr. 1986 Dec;6(4):239–241. doi: 10.1080/02724936.1986.11748448. [DOI] [PubMed] [Google Scholar]
  2. Alward W. L., McMahon B. J., Hall D. B., Heyward W. L., Francis D. P., Bender T. R. The long-term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma. J Infect Dis. 1985 Apr;151(4):604–609. doi: 10.1093/infdis/151.4.604. [DOI] [PubMed] [Google Scholar]
  3. Anderson R. M., May R. M. Vaccination against rubella and measles: quantitative investigations of different policies. J Hyg (Lond) 1983 Apr;90(2):259–325. doi: 10.1017/s002217240002893x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. André F. E. Overview of a 5-year clinical experience with a yeast-derived hepatitis B vaccine. Vaccine. 1990 Mar;8 (Suppl):S74–S80. doi: 10.1016/0264-410x(90)90222-8. [DOI] [PubMed] [Google Scholar]
  5. Barin F., Perrin J., Chotard J., Denis F., N'Doye R., Diop Mar I., Chiron J. P., Coursaget P., Goudeau A., Maupas P. Cross-sectional and longitudinal epidemiology of hepatitis B in Senegal. Prog Med Virol. 1981;27:148–162. [PubMed] [Google Scholar]
  6. Beasley R. P., Hwang L. Y., Lee G. C., Lan C. C., Roan C. H., Huang F. Y., Chen C. L. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet. 1983 Nov 12;2(8359):1099–1102. doi: 10.1016/s0140-6736(83)90624-4. [DOI] [PubMed] [Google Scholar]
  7. Beasley R. P., Hwang L. Y., Lin C. C., Chien C. S. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet. 1981 Nov 21;2(8256):1129–1133. doi: 10.1016/s0140-6736(81)90585-7. [DOI] [PubMed] [Google Scholar]
  8. Beasley R. P., Hwang L. Y., Lin C. C., Stevens C. E., Wang K. Y., Sun T. S., Hsieh F. J., Szmuness W. Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Initial report of a randomised double-blind placebo-controlled trial. Lancet. 1981 Aug 22;2(8243):388–393. doi: 10.1016/s0140-6736(81)90832-1. [DOI] [PubMed] [Google Scholar]
  9. Beasley R. P., Trepo C., Stevens C. E., Szmuness W. The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol. 1977 Feb;105(2):94–98. doi: 10.1093/oxfordjournals.aje.a112370. [DOI] [PubMed] [Google Scholar]
  10. Biswas S. C., Gupta I., Ganguly N. K., Chawla Y., Dilawari J. B. Prevalence of hepatitis B surface antigen in pregnant mothers and its perinatal transmission. Trans R Soc Trop Med Hyg. 1989 Sep-Oct;83(5):698–700. doi: 10.1016/0035-9203(89)90401-x. [DOI] [PubMed] [Google Scholar]
  11. Bortolotti F., Cadrobbi P., Crivellaro C., Bertaggia A., Alberti A., Realdi G. Chronic hepatitis type B in childhood: longitudinal study of 35 cases. Gut. 1981 Jun;22(6):499–504. doi: 10.1136/gut.22.6.499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Bortolotti F., Cadrobbi P., Crivellaro C., Guido M., Rugge M., Noventa F., Calzia R., Realdi G. Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus infection in childhood. Gastroenterology. 1990 Sep;99(3):805–810. doi: 10.1016/0016-5085(90)90972-4. [DOI] [PubMed] [Google Scholar]
  13. Botha J. F., Ritchie M. J., Dusheiko G. M., Mouton H. W., Kew M. C. Hepatitis B virus carrier state in black children in Ovamboland: role of perinatal and horizontal infection. Lancet. 1984 Jun 2;1(8388):1210–1212. doi: 10.1016/s0140-6736(84)91694-5. [DOI] [PubMed] [Google Scholar]
  14. Boutin J. P., Sainte Marie F. F., Cartel J. L., Cardines R., Girard M., Roux J. Prevalence of hepatitis B virus infection in the Austral archipelago, French Polynesia: identification of transmission patterns for the formulation of immunization strategies. Trans R Soc Trop Med Hyg. 1990 Mar-Apr;84(2):283–287. doi: 10.1016/0035-9203(90)90288-p. [DOI] [PubMed] [Google Scholar]
  15. Bowry T. R. Seroepidemiology of hepatitis B in an urban population of Nairobi, Kenya. J Infect Dis. 1983 Dec;148(6):1122–1122. doi: 10.1093/infdis/148.6.1122. [DOI] [PubMed] [Google Scholar]
  16. Chen D. S., Sung J. L., Lai M. Y., Sheu J. C., Yang P. M., Lee S. C., Chen S. H., Chang M. H., Ko T. M., Lee T. Y. Inadequacy of immunoglobulin M hepatitis B core antibody in detecting acute hepatitis B virus infection in infants of HBsAg carrier mothers. J Med Virol. 1985 Aug;16(4):309–314. doi: 10.1002/jmv.1890160402. [DOI] [PubMed] [Google Scholar]
  17. Chung D. C., Ko Y. C., Chen C. J., Wu C. C., Chen E. R., Liaw Y. F., Hwang S. J. Seroepidemiological studies on hepatitis B and D viruses infection among five ethnic groups in southern Taiwan. J Med Virol. 1988 Dec;26(4):411–418. doi: 10.1002/jmv.1890260408. [DOI] [PubMed] [Google Scholar]
  18. Coursaget P., Yvonnet B., Chotard J., Sarr M., Vincelot P., N'doye R., Diop-Mar I., Chiron J. P. Seven-year study of hepatitis B vaccine efficacy in infants from an endemic area (Senegal). Lancet. 1986 Nov 15;2(8516):1143–1145. doi: 10.1016/s0140-6736(86)90543-x. [DOI] [PubMed] [Google Scholar]
  19. Coursaget P., Yvonnet B., Chotard J., Vincelot P., Sarr M., Diouf C., Chiron J. P., Diop-Mar I. Age- and sex-related study of hepatitis B virus chronic carrier state in infants from an endemic area (Senegal). J Med Virol. 1987 May;22(1):1–5. doi: 10.1002/jmv.1890220102. [DOI] [PubMed] [Google Scholar]
  20. Coursaget P., Yvonnet B., Gilks W. R., Wang C. C., Day N. E., Chiron J. P., Diop-Mar I. Scheduling of revaccination against hepatitis B virus. Lancet. 1991 May 18;337(8751):1180–1183. doi: 10.1016/0140-6736(91)92857-x. [DOI] [PubMed] [Google Scholar]
  21. De Virgiliis S., Frau F., Sanna G., Turco M. P., Figus A. L., Cornacchia G., Cao A. Perinatal hepatitis B virus detection by hepatitis B virus-DNA analysis. Arch Dis Child. 1985 Jan;60(1):56–58. doi: 10.1136/adc.60.1.56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Deinhardt F. Predictive value of markers of hepatitis virus infection. J Infect Dis. 1980 Mar;141(3):299–305. doi: 10.1093/infdis/141.3.299. [DOI] [PubMed] [Google Scholar]
  23. Derso A., Boxall E. H., Tarlow M. J., Flewett T. H. Transmission of HBsAg from mother to infant in four ethnic groups. Br Med J. 1978 Apr 15;1(6118):949–952. doi: 10.1136/bmj.1.6118.949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Edmunds W. J., Medley G. F., Nokes D. J., Hall A. J., Whittle H. C. The influence of age on the development of the hepatitis B carrier state. Proc Biol Sci. 1993 Aug 23;253(1337):197–201. doi: 10.1098/rspb.1993.0102. [DOI] [PubMed] [Google Scholar]
  25. Feret E., Larouze B., Diop B., Sow M., London W. T., Blumberg B. S. Epidemiology of hepatitis B virus infection in the rural community of Tip, Senegal. Am J Epidemiol. 1987 Jan;125(1):140–149. doi: 10.1093/oxfordjournals.aje.a114497. [DOI] [PubMed] [Google Scholar]
  26. Gebreselassie L. Prevalence of specific markers of viral hepatitis A and B among an Ethiopian population. Bull World Health Organ. 1983;61(6):991–996. [PMC free article] [PubMed] [Google Scholar]
  27. Ghendon Y. WHO strategy for the global elimination of new cases of hepatitis B. Vaccine. 1990 Mar;8 (Suppl):S129–S138. doi: 10.1016/0264-410x(90)90233-c. [DOI] [PubMed] [Google Scholar]
  28. Goudeau A., Yvonnet B., Lesage G., Barin F., Denis F., Coursaget P., Chiron J. P., Diop Mar I. Lack of anti-HBc IgM in neonates with HBsAg carrier mothers argues against transplacental transmission of hepatitis B virus infection. Lancet. 1983 Nov 12;2(8359):1103–1104. doi: 10.1016/s0140-6736(83)90625-6. [DOI] [PubMed] [Google Scholar]
  29. Greenfield C., Osidiana V., Karayiannis P., Galpin S., Musoke R., Jowett T. P., Mati P., Tukei P. M., Thomas H. C. Perinatal transmission of hepatitis B virus in Kenya: its relation to the presence of serum HBV-DNA and anti-HBe in the mother. J Med Virol. 1986 Jun;19(2):135–142. doi: 10.1002/jmv.1890190205. [DOI] [PubMed] [Google Scholar]
  30. Grenfell B. T., Anderson R. M. The estimation of age-related rates of infection from case notifications and serological data. J Hyg (Lond) 1985 Oct;95(2):419–436. doi: 10.1017/s0022172400062859. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Haukenes G., Shao J. F., Mbena E., Rustad S. Hepatitis B virus markers in the population of Dar es Salaam, Tanzania. J Infect. 1987 Sep;15(2):183–188. doi: 10.1016/s0163-4453(87)93249-x. [DOI] [PubMed] [Google Scholar]
  32. Hu M., Schenzle D., Deinhardt F., Scheid R. Prevalence of markers of hepatitis A and B in the Shanghai area. J Infect Dis. 1983 Feb;147(2):360–360. doi: 10.1093/infdis/147.2.360. [DOI] [PubMed] [Google Scholar]
  33. Hwang L. Y., Roggendorf M., Beasley R. P., Deinhardt F. Perinatal transmission of hepatitis B virus: role of maternal HBeAg and anti-HBc IgM. J Med Virol. 1985 Mar;15(3):265–269. doi: 10.1002/jmv.1890150307. [DOI] [PubMed] [Google Scholar]
  34. Hyams K. C., Osman N. M., Khaled E. M., Koraa A. A., Imam I. Z., el-Ghorab N. M., Dunn M. A., Woody J. N. Maternal-infant transmission of hepatitis B in Egypt. J Med Virol. 1988 Feb;24(2):191–197. doi: 10.1002/jmv.1890240208. [DOI] [PubMed] [Google Scholar]
  35. Hyams K. C., al-Arabi M. A., al-Tagani A. A., Messiter J. F., al-Gaali A. A., George J. F. Epidemiology of hepatitis B in the Gezira region of Sudan. Am J Trop Med Hyg. 1989 Feb;40(2):200–206. doi: 10.4269/ajtmh.1989.40.200. [DOI] [PubMed] [Google Scholar]
  36. Iwarson S., Hermodsson S. Hepatitis-associated antigen (HAA) in acute viral hepatitis. Serological and clinical studies. Scand J Infect Dis. 1971;3(2):93–101. doi: 10.3109/inf.1971.3.issue-2.01. [DOI] [PubMed] [Google Scholar]
  37. Kashiwagi S., Hayashi J., Ikematsu H., Nomura H., Kajiyama W., Shingu T., Hayashida K., Kaji M. Transmission of hepatitis B virus among siblings. Am J Epidemiol. 1984 Oct;120(4):617–625. doi: 10.1093/oxfordjournals.aje.a113923. [DOI] [PubMed] [Google Scholar]
  38. Lau Y. L., Chow C. B., Leung T. H. Changing epidemiology of measles in Hong Kong from 1961 to 1990--impact of a measles vaccination program. J Infect Dis. 1992 Jun;165(6):1111–1115. doi: 10.1093/infdis/165.6.1111. [DOI] [PubMed] [Google Scholar]
  39. Lee A. K., Ip H. M., Wong V. C. Mechanisms of maternal-fetal transmission of hepatitis B virus. J Infect Dis. 1978 Nov;138(5):668–671. doi: 10.1093/infdis/138.5.668. [DOI] [PubMed] [Google Scholar]
  40. Lingao A. L., Domingo E. O., West S., Reyes C. M., Gasmen S., Viterbo G., Tiu E., Lansang M. A. Seroepidemiology of hepatitis B virus in the Philippines. Am J Epidemiol. 1986 Mar;123(3):473–480. doi: 10.1093/oxfordjournals.aje.a114262. [DOI] [PubMed] [Google Scholar]
  41. Margolis H. S. Prevention of acute and chronic liver disease through immunization: hepatitis B and beyond. J Infect Dis. 1993 Jul;168(1):9–14. doi: 10.1093/infdis/168.1.9. [DOI] [PubMed] [Google Scholar]
  42. Marinier E., Barrois V., Larouze B., London W. T., Cofer A., Diakhate L., Blumberg B. S. Lack of perinatal transmission of hepatitis B virus infection in Senegal, West Africa. J Pediatr. 1985 May;106(5):843–849. doi: 10.1016/s0022-3476(85)80371-1. [DOI] [PubMed] [Google Scholar]
  43. Maynard J. E., Kane M. A., Hadler S. C. Global control of hepatitis B through vaccination: role of hepatitis B vaccine in the Expanded Programme on Immunization. Rev Infect Dis. 1989 May-Jun;11 (Suppl 3):S574–S578. doi: 10.1093/clinids/11.supplement_3.s574. [DOI] [PubMed] [Google Scholar]
  44. Mazzur S., Bastiaans M. J., Nath N. Hepatitis B virus (HBV) infection among children and adults in the Solomon Islands. Am J Epidemiol. 1981 May;113(5):510–519. doi: 10.1093/oxfordjournals.aje.a113126. [DOI] [PubMed] [Google Scholar]
  45. McMahon B. J., Alberts S. R., Wainwright R. B., Bulkow L., Lanier A. P. Hepatitis B-related sequelae. Prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers. Arch Intern Med. 1990 May;150(5):1051–1054. doi: 10.1001/archinte.150.5.1051. [DOI] [PubMed] [Google Scholar]
  46. McMahon B. J., Alward W. L., Hall D. B., Heyward W. L., Bender T. R., Francis D. P., Maynard J. E. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis. 1985 Apr;151(4):599–603. doi: 10.1093/infdis/151.4.599. [DOI] [PubMed] [Google Scholar]
  47. McMahon B. J., Parkinson A. J., Helminiak C., Wainwright R. B., Bulkow L., Kellerman-Douglas A., Schoenberg S., Ritter D. Response to hepatitis B vaccine of persons positive for antibody to hepatitis B core antigen. Gastroenterology. 1992 Aug;103(2):590–594. doi: 10.1016/0016-5085(92)90851-o. [DOI] [PubMed] [Google Scholar]
  48. Milne A., Allwood G. K., Moyes C. D., Pearce N. E., Lucas C. R. Prevalence of hepatitis B infections in a multiracial New Zealand community. N Z Med J. 1985 Jul 10;98(782):529–532. [PubMed] [Google Scholar]
  49. Nayak N. C., Panda S. K., Zuckerman A. J., Bhan M. K., Guha D. K. Dynamics and impact of perinatal transmission of hepatitis B virus in North India. J Med Virol. 1987 Feb;21(2):137–145. doi: 10.1002/jmv.1890210205. [DOI] [PubMed] [Google Scholar]
  50. Nielsen J. O., Dietrichson O., Elling P., Christoffersen P. Incidence and meaning of persistence of Australia antigen in patients with acute viral hepatitis: development of chronic hepatitis. N Engl J Med. 1971 Nov 18;285(21):1157–1160. doi: 10.1056/NEJM197111182852101. [DOI] [PubMed] [Google Scholar]
  51. Okada K., Yamada T., Miyakawa Y., Mayumi M. Hepatitis B surface antigen in the serum of infants after deliver from asymptomatic carrier mothers. J Pediatr. 1975 Sep;87(3):360–363. doi: 10.1016/s0022-3476(75)80635-4. [DOI] [PubMed] [Google Scholar]
  52. Okada K., Yamada T., Miyakawa Y., Mayumi M. Hepatitis B surface antigen in the serum of infants after deliver from asymptomatic carrier mothers. J Pediatr. 1975 Sep;87(3):360–363. doi: 10.1016/s0022-3476(75)80635-4. [DOI] [PubMed] [Google Scholar]
  53. Panda S. K., Bhan M. K., Guha D. K., Gupta A., Datta R., Zuckerman A. J., Nayak N. C. Significance of maternal and infant serum antibodies to hepatitis B core antigen in hepatitis B virus infection of infancy. J Med Virol. 1988 Mar;24(3):343–349. doi: 10.1002/jmv.1890240311. [DOI] [PubMed] [Google Scholar]
  54. Panda S. K., Gupta A., Datta R., Nayak N. C. Transplacental transmission of hepatitis B virus. Lancet. 1986 Oct 18;2(8512):919–920. doi: 10.1016/s0140-6736(86)90439-3. [DOI] [PubMed] [Google Scholar]
  55. Pearce N., Milne A., Moyes C. Hepatitis B virus: the importance of age at infection. N Z Med J. 1988 Nov 23;101(858):788–790. [PubMed] [Google Scholar]
  56. Prince A. M. An antigen detected in the blood during the incubation period of serum hepatitis. Proc Natl Acad Sci U S A. 1968 Jul;60(3):814–821. doi: 10.1073/pnas.60.3.814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Prozesky O. W., Szmuness W., Stevens C. E., Kew M. C., Harley E. J., Hoyland J. A., Scholtz J. E., Mitchell A. D., Shabangu A., Kunene E. Baseline epidemiological studies for a hepatitis B vaccine trial in Kangwane. S Afr Med J. 1983 Nov 26;64(23):891–893. [PubMed] [Google Scholar]
  58. Reniers J., Vranckx R., Ngantung W., Sugita E., Meheus A. Prevalence and determinants of hepatitis B virus markers in pregnant women in West Java, Indonesia. J Trop Med Hyg. 1987 Oct;90(5):249–253. [PubMed] [Google Scholar]
  59. Schweitzer I. L., Mosley J. W., Ashcaval M., Edwards V. M., Overby L. B. Factors influencing neonatal infection by hepatitis B virus. Gastroenterology. 1973 Aug;65(2):277–283. [PubMed] [Google Scholar]
  60. Schweitzer I. L. Vertical transmission of the hepatitis B surface antigen. Am J Med Sci. 1975 Sep-Oct;270(2):287–291. doi: 10.1097/00000441-197509000-00008. [DOI] [PubMed] [Google Scholar]
  61. Shiraki K., Yoshihara N., Kawana T., Yasui H., Sakurai M. Hepatitis B surface antigen and chronic hepatitis in infants born to asymptomatic carrier mothers. Am J Dis Child. 1977 Jun;131(6):644–647. doi: 10.1001/archpedi.1977.02120190038007. [DOI] [PubMed] [Google Scholar]
  62. Shiraki K., Yoshihara N., Sakurai M., Eto T., Kawana T. Acute hepatitis B in infants born to carrier mother with the antibody to hepatitis B e antigen. J Pediatr. 1980 Nov;97(5):768–770. doi: 10.1016/s0022-3476(80)80261-7. [DOI] [PubMed] [Google Scholar]
  63. Sobeslavský O. Prevalence of markers of hepatitis B virus infection in various countries: a WHO collaborative study. Bull World Health Organ. 1980;58(4):621–628. [PMC free article] [PubMed] [Google Scholar]
  64. Stevens C. E., Beasley R. P., Tsui J., Lee W. C. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med. 1975 Apr 10;292(15):771–774. doi: 10.1056/NEJM197504102921503. [DOI] [PubMed] [Google Scholar]
  65. Stevens C. E., Neurath R. A., Beasley R. P., Szmuness W. HBeAg and anti-HBe detection by radioimmunoassay: correlation with vertical transmission of hepatitis B virus in Taiwan. J Med Virol. 1979;3(3):237–241. doi: 10.1002/jmv.1890030310. [DOI] [PubMed] [Google Scholar]
  66. Suvatte V., Assateerawatts A. Vertical transmission of the hepatitis B surface antigen in Thailand. Southeast Asian J Trop Med Public Health. 1980 Dec;11(4):582–587. [PubMed] [Google Scholar]
  67. Tabor E., Bayley A. C., Cairns J., Pelleu L., Gerety R. J. Horizontal transmission of hepatitis B virus among children and adults in five rural villages in Zambia. J Med Virol. 1985 Feb;15(2):113–120. doi: 10.1002/jmv.1890150203. [DOI] [PubMed] [Google Scholar]
  68. Tassopoulos N. C., Papaevangelou G. J., Sjogren M. H., Roumeliotou-Karayannis A., Gerin J. L., Purcell R. H. Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults. Gastroenterology. 1987 Jun;92(6):1844–1850. doi: 10.1016/0016-5085(87)90614-7. [DOI] [PubMed] [Google Scholar]
  69. Tong M. J., Thursby M. W., Lin J. H., Weissman J. Y., McPeak C. M. Studies on the maternal-infant transmission of the hepatitis B virus and HBV infection within families. Prog Med Virol. 1981;27:137–147. [PubMed] [Google Scholar]
  70. Torres J. R., Mondolfi A. Protracted outbreak of severe delta hepatitis: experience in an isolated Amerindian population of the Upper Orinoco basin. Rev Infect Dis. 1991 Jan-Feb;13(1):52–55. doi: 10.1093/clinids/13.1.52. [DOI] [PubMed] [Google Scholar]
  71. Toukan A. U., Sharaiha Z. K., Abu-el-Rub O. A., Hmoud M. K., Dahbour S. S., Abu-Hassan H., Yacoub S. M., Hadler S. C., Margolis H. S., Coleman P. J. The epidemiology of hepatitis B virus among family members in the Middle East. Am J Epidemiol. 1990 Aug;132(2):220–232. doi: 10.1093/oxfordjournals.aje.a115651. [DOI] [PubMed] [Google Scholar]
  72. Tsega E., Tsega M., Mengesha B., Nordenfelt E., Hansson B. G., Lindberg J. Transmission of hepatitis B virus infection in Ethiopia with emphasis on the importance of vertical transmission. Int J Epidemiol. 1988 Dec;17(4):874–879. doi: 10.1093/ije/17.4.874. [DOI] [PubMed] [Google Scholar]
  73. Whittle H. C., Inskip H., Hall A. J., Mendy M., Downes R., Hoare S. Vaccination against hepatitis B and protection against chronic viral carriage in The Gambia. Lancet. 1991 Mar 30;337(8744):747–750. doi: 10.1016/0140-6736(91)91367-4. [DOI] [PubMed] [Google Scholar]
  74. Whittle H., Inskip H., Bradley A. K., McLaughlan K., Shenton F., Lamb W., Eccles J., Baker B. A., Hall A. J. The pattern of childhood hepatitis B infection in two Gambian villages. J Infect Dis. 1990 Jun;161(6):1112–1115. doi: 10.1093/infdis/161.6.1112. [DOI] [PubMed] [Google Scholar]
  75. Wong V. C., Ip H. M., Reesink H. W., Lelie P. N., Reerink-Brongers E. E., Yeung C. Y., Ma H. K. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study. Lancet. 1984 Apr 28;1(8383):921–926. doi: 10.1016/s0140-6736(84)92388-2. [DOI] [PubMed] [Google Scholar]
  76. Wong V. C., Lee A. K., Ip H. M. Transmission of hepatitis B antigens from symptom free carrier mothers to the fetus and the infant. Br J Obstet Gynaecol. 1980 Nov;87(11):958–965. doi: 10.1111/j.1471-0528.1980.tb04458.x. [DOI] [PubMed] [Google Scholar]

Articles from Epidemiology and Infection are provided here courtesy of Cambridge University Press

RESOURCES